Synapse - Kylee Maclachlan

Results (157)

Positive selection as the unifying force for clonal evolution in multiple myeloma

Research Letter

Diamond, B.; Yellapantula, V.; Rustad, E. H.; Maclachlan, K. H.; Mayerhoefer, M.; Kaiser, M.; Morgan, G.; Landgren, O.; Maura, F.
Leukemia (2021)

Fulltext@MSK | Save

Initial whole-genome sequencing of plasma cell neoplasms in first responders and recovery workers exposed to the World Trade Center attack of September 11, 2001

Journal Article

Maura, F.; Diamond, B.; Maclachlan, K. H.; Derkach, A.; Yellapantula, V. D.; Rustad, E. H.; Hultcrantz, M.; Shah, U. A.; Hong, J.; Landau, H. J.; more...
Clinical Cancer Research (2021)

Fulltext@MSK | Save

Improving prognostic assignment in older age groups of multiple myeloma

Meeting Abstract

Boyle, E. M.; Litke, R. R.; Blaney, P.; Ashby, T. C.; Bauer, M.; Walker, B.; Ghamlouch, H.; Choi, J.; Perrial, E.; Wang, Y.; more...
Journal of the American Geriatrics Society (2021)

Fulltext@MSK | Save

Minimal residual disease in multiple myeloma: Defining the role of next generation sequencing and flow cytometry in routine diagnostic use

Review

Maclachlan, K. H.; Came, N.; Diamond, B.; Roshal, M.; Ho, C.; Thoren, K.; Mayerhoefer, M. E.; Landgren, O.; Harrison, S.
Pathology (2021)

Fulltext@MSK | Save

Whole-genome sequencing reveals progressive versus stable myeloma precursor conditions as two distinct entities

Journal Article

Oben, B.; Froyen, G.; Maclachlan, K. H.; Leongamornlert, D.; Abascal, F.; Zheng-Lin, B.; Yellapantula, V.; Derkach, A.; Geerdens, E.; Diamond, B. T.; more...
Nature Communications (2021)

Fulltext@MSK | Save

Defining the undetectable: The current landscape of minimal residual disease assessment in multiple myeloma and goals for future clarity

Review

Diamond, B. T.; Rustad, E.; Maclachlan, K.; Thoren, K.; Ho, C.; Roshal, M.; Ulaner, G. A.; Landgren, C. O.
Blood Reviews (2021)

Fulltext@MSK | Save

Revealing the impact of structural variants in multiple myeloma

Journal Article

Rustad, E. H.; Yellapantula, V. D.; Glodzik, D.; Maclachlan, K. H.; Diamond, B.; Boyle, E. M.; Ashby, C.; Blaney, P.; Gundem, G.; Hultcrantz, M.; more...
Blood Cancer Discovery (2020)

Fulltext@MSK | Save

Duration of post-autologous hematopoietic cell transplant anemia and thrombocytopenia are associated with prolonged hospital length-of-stay for multiple myeloma patients

Meeting Abstract

Zheng-Lin, B.; Krishnamurthi, N.; Diamond, B.; Maclachlan, K. H.; Maura, F.; Landgren, O.; Chung, D. J.
Blood (2020)

Fulltext@MSK | Save

Whole-genome sequencing reveals evidence of two biologically and clinically distinct entities: Progressive versus stable myeloma precursor disease

Meeting Abstract

Oben, B.; Froyen, G.; Maclachlan, K. H.; Zheng-Lin, B.; Yellapantula, V.; Abascal, F.; Leongamornlert, D. A.; Derkach, A.; Geerdens, E.; Diamond, B.; more...
Blood (2020)

Fulltext@MSK | Save

Copy number signatures predict chromothripsis and poor clinical outcome in newly diagnosed multiple myeloma patients

Meeting Abstract

Maclachlan, K. H.; Zheng-Lin, B.; Yellapantula, V.; Derkach, A.; Rustad, E. H.; Diamond, B.; Hultcrantz, M.; Dogan, A.; Zhang, Y.; Morgan, G.; more...
Blood (2020)

Fulltext@MSK | Save